This site has been optimized to work with modern browsers and does not fully support your version of Internet Explorer.

News (Research)rss feed

Currently Filtering By:Research clear filter

The Duke of Westminster donates £1m to Oxford University’s COVID-19 mental health research

Hugh Grosvenor, The Duke of Westminster, has donated £1m towards Oxford University’s COVID-19 mental health research programmes. This is part of the £10m donation announced by the Westminster Foundation last month to support the national COVID-19 relief effort. The grant will be made available through the Westminster Foundation to support the University’s Department of Psychiatry, which […]

HCQ with antibiotics to treat COVID-19 could be dangerous for the heart

Researchers from the Department of Physiology, Anatomy & Genetics (DPAG) have collaborated on an international study that demonstrates a detailed mechanistic understanding of how the anti-malaria drug, Hydroxychloroquine, combined with antibiotics, can cause adverse cardiac side-effects in COVID-19 patients. This gives weight to US Federal advice against using this combined treatment. Hydroxychloroquine (HCQ), a drug normally […]

New weight-loss drug brings hope for safer obesity treatment

A collaborative research team from the Universities of Oxford and Cambridge, co-led by Department of Physiology, Anatomy & Genetics Associate Professor Ana Domingos, have developed a new weight-loss amphetamine that could potentially avoid the harmful side effects of traditional treatments. © CireniaSketches Obesity is a major health issue across the world and is implicated in […]

OAHP supporting the research effort

The NIHR and UK Research and Innovation (UKRI) have awarded £10.5 million of funding to six new research projects on developing and testing vaccines and therapies for the novel coronavirus (COVID-19). One of the projects will investigate potential vaccines and could begin as early as June. Another of the funded projects will develop manufacturing processes to […]

Analysis of antipsychotic drugs could improve outcomes for schizophrenia patients

Analysis of antipsychotic drugs could improve outcomes for schizophrenia patients Results of a new study published in The Lancet this month will help doctors to balance the benefits and side-effects of medication they prescribe to treat schizophrenia. Schizophrenia is one of the most common psychiatric disorders in adults worldwide – one in 100 people globally […]

Clinical researchers at Oxford University announce new collaboration with Janssen to detect blood cancers sooner

The new 7-year research collaboration with Janssen Research & Development, LLC (Janssen) will study patients at higher risk of developing certain types of blood cancers that arise from the immune system, such as chronic lymphocytic leukaemia and multiple myeloma, to identify markers that could be used to predict who will go on to develop symptomatic […]

Oxford spinout company launched to diagnose Alzheimer’s Disease from MRI scans

Oxford Brain Diagnostics, a spinout from Oxford University, has been launched to deliver a new method for diagnosing Alzheimer’s Disease from MRI scans. © Shutterstock The company is already engaged with pharmaceutical and biotech companies to help support them to accelerate the development of effective new drugs and treatments for Alzheimer’s Disease. The company will […]

Excellence payments to hospitals improve hip fracture care

A scheme that pays hospitals to deliver high quality care has been shown to improve the outcomes for patients with broken hips in England. © Shutterstock Hip fractures are a major cause of death and disability among older people worldwide, with 70,000 cases every year in the UK, which cost the NHS around £2 billion. […]

Pagination